Edition:
United States

Alimera Sciences Inc (ALIM.O)

ALIM.O on Consolidated Issue listed on NASDAQ Global Market

1.39USD
18 Aug 2017
Change (% chg)

$-0.02 (-1.42%)
Prev Close
$1.41
Open
$1.40
Day's High
$1.42
Day's Low
$1.35
Volume
87,582
Avg. Vol
362,412
52-wk High
$1.72
52-wk Low
$1.03

Select another date:

Wed, Aug 2 2017

BRIEF-Alimera Sciences Q2 ‍net loss per share $0.04​

* Alimera Sciences reports second quarter 2017 financial results

BRIEF-Alimera Sciences announces real-world audit data supporting positive benefits of iluvien treatment

* Alimera Sciences announces real-world audit data supporting the positive benefits of iluvien treatment

BRIEF-Alimera Sciences announces italian patients now being treated with Iluvien

* Alimera Sciences announces italian patients now being treated with Iluvien® Source text for Eikon: Further company coverage:

BRIEF-pSivida- in connection with new collaboration agreement, Alimera forgave $10 mln of co's share of losses associated with commercialization of ILUVIEN

* pSivida - in connection with new collaboration agreement, alimera forgave $10 million of co's share of losses associated with commercialization of ILUVIEN

BRIEF-ALIMERA SCIENCES REPORTS Q1 LOSS PER SHARE $0.10

* ALIMERA SCIENCES REPORTS FIRST QUARTER 2017 FINANCIAL RESULTS

BRIEF-Alimera Sciences signs agreement for exclusive distributor of Iluvien in Spain

* Alimera Sciences signs agreement for exclusive distributor of Iluvien in Spain

BRIEF-Alimera Sciences Q4 adjusted non-gaap loss per share $0.10

* Alimera sciences reports record fourth quarter and full year 2016 financial results

BRIEF-Alimera Sciences and Knight Therapeutics file new drug submission for iluvien in Canada

* Alimera Sciences and Knight Therapeutics announce filing of new drug submission for iluvien in Canada

Select another date: